Literature DB >> 23143544

Criteria for clinical stability in hospitalised patients with community-acquired pneumonia.

Stefano Aliberti1, Anna Maria Zanaboni, Tim Wiemken, Ahmed Nahas, Srinivas Uppatla, Letizia Corinna Morlacchi, Paula Peyrani, Francesco Blasi, Julio Ramirez.   

Abstract

The American Thoracic Society (ATS) and Infectious Diseases Society of America (IDSA) suggested two sets of criteria in 2001 and 2007 to define clinical stability in community-acquired pneumonia (CAP). The present study aimed to evaluate the level of agreement between these two sets of criteria and how well they can predict clinical outcomes. A retrospective cohort study was carried out of 487 consecutive patients hospitalised with CAP. Level of agreement was tested using a survival curve analysis, while prediction of outcomes at 30-day follow-up was evaluated through receiver operating characteristic (ROC) analysis. A discrepancy between ATS 2001 and ATS/IDSA 2007 criteria in identifying clinical stability was detected in 62% of the patients. The median (interquartile range) time to clinical stability was 2 (1-4) days based on ATS 2001 and 3 (2-5) days based on ATS/IDSA 2007 criteria (p = 0.012). The daily distribution of patients who reached clinical stability evaluated with both sets was different (p = 0.002). The ROC analysis showed an area under the curve of 0.705 for the ATS 2001 criteria and 0.714 for ATS/IDSA 2007 criteria (p = 0.645). ATS 2001 and ATS/IDSA 2007 criteria for clinical stability in hospitalised patients with CAP are clinically equivalent and both can be used in clinical practice as well as in clinical research.

Entities:  

Mesh:

Year:  2012        PMID: 23143544     DOI: 10.1183/09031936.00100812

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  15 in total

1.  Duration of Antibiotic Use Among Adults With Uncomplicated Community-Acquired Pneumonia Requiring Hospitalization in the United States.

Authors:  Sarah H Yi; Kelly M Hatfield; James Baggs; Lauri A Hicks; Arjun Srinivasan; Sujan Reddy; John A Jernigan
Journal:  Clin Infect Dis       Date:  2018-04-17       Impact factor: 9.079

Review 2.  Predictors of treatment failure and clinical stability in patients with community acquired pneumonia.

Authors:  Deirdre Morley; Antoni Torres; Catia Cillóniz; Ignacio Martin-Loeches
Journal:  Ann Transl Med       Date:  2017-11

Review 3.  The management of community-acquired pneumonia in the elderly.

Authors:  Paola Faverio; Stefano Aliberti; Giuseppe Bellelli; Giulia Suigo; Sara Lonni; Alberto Pesci; Marcos I Restrepo
Journal:  Eur J Intern Med       Date:  2013-12-17       Impact factor: 4.487

4.  Socioeconomic Position and the Incidence, Severity, and Clinical Outcomes of Hospitalized Patients With Community-Acquired Pneumonia.

Authors:  Timothy L Wiemken; Ruth M Carrico; Stephen P Furmanek; Brian E Guinn; William A Mattingly; Paula Peyrani; Julio A Ramirez
Journal:  Public Health Rep       Date:  2020-03-31       Impact factor: 2.792

5.  Predictors and Implications of Early Clinical Stability in Patients Hospitalized for Moderately Severe Community-Acquired Pneumonia.

Authors:  Nicolas Garin; Garance Felix; Christian Chuard; Daniel Genné; Sebastian Carballo; Olivier Hugli; Olivier Lamy; Christophe Marti; Mathieu Nendaz; Olivier Rutschmann; Stephan Harbarth; Arnaud Perrier
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

6.  Acute myocardial infarction versus other cardiovascular events in community-acquired pneumonia.

Authors:  Stefano Aliberti; Julio Ramirez; Roberto Cosentini; Vincenzo Valenti; Antonio Voza; Paolo Rossi; Daiana Stolz; Delfino Legnani; Alberto Pesci; Luca Richeldi; Paula Peyrani; Fernando Maria Massari; Francesco Blasi
Journal:  ERJ Open Res       Date:  2015-09-15

7.  Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study.

Authors:  Stefano Aliberti; Letizia Corinna Morlacchi; Paola Faverio; Rafael Fernandez-Botran; Roberto Cosentini; Marco Mantero; Paula Peyrani; Julio Ramirez; Jose Bordon; Francesco Blasi
Journal:  Pneumonia (Nathan)       Date:  2016-06-23

8.  Utilisation of a Suite of Screening Tools to Determine Adverse Healthcare Outcomes in an Older Frail Population Admitted to a Community Virtual Ward.

Authors:  Clare Lewis; Rónán O'Caoimh; Declan Patton; Tom O'Connor; Zena Moore; Linda E Nugent
Journal:  Int J Environ Res Public Health       Date:  2021-05-24       Impact factor: 3.390

9.  Cardiovascular autonomic alterations in hospitalized patients with community-acquired pneumonia.

Authors:  Stefano Aliberti; Eleonora Tobaldini; Fabio Giuliani; Vanessa Nunziata; Giovanni Casazza; Giulia Suigo; Alice D'Adda; Giulia Bonaiti; Andrea Roveda; Andreia Queiroz; Valter Monzani; Alberto Pesci; Francesco Blasi; Nicola Montano
Journal:  Respir Res       Date:  2016-08-04

10.  Individual and health system variation in rehospitalizations the year after pneumonia.

Authors:  Elizabeth M Viglianti; Hallie C Prescott; Vincent Liu; Gabriel J Escobar; Theodore J Iwashyna
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.